BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260817
DTEND;VALUE=DATE:20260820
DTSTAMP:20260528T105202Z
CREATED:20260528T105202Z
LAST-MODIFIED:20260528T105202Z
UID:43613-1786924800-1787183999@www.pharmajournalist.com
SUMMARY:5th Oligonucleotides Analytical Development & CMC Summit
DESCRIPTION:Taking place in Boston (August 17–19\, 2026)\, the 5th Oligonucleotide Analytical Development & CMC Summit is a premier event dedicated to advancing analytical and CMC strategies for oligonucleotide therapeutics. Bringing together experts from Alnylam\, Biogen\, Ionis Pharmaceuticals\, Amgen\, and Avidity Biosciences\, the meeting tackles key challenges in impurity control\, complex chemistries\, and scalable manufacturing. Attendees will gain insights into cutting-edge analytical tools including mass spectrometry and sequencing\, alongside evolving global regulatory expectations. Covering modalities such as ASOs\, siRNA\, and conjugates\, the summit provides practical frameworks to improve product quality\, comparability\, and regulatory readiness. Connect with 90+ industry leaders and accelerate development from early-stage research through to commercialization. Visit the website for more information. \nTo learn more and register online\, please visit: https://ter.li/l10canku
URL:http://www.pharmajournalist.com/event/5th-oligonucleotides-analytical-development-cmc-summit/
LOCATION:The Colonnade Hotel\, 120 Huntington Ave\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR